Mubadala Healthcare and NYU Abu Dhabi (NYUAD) have signed a Memorandum of Understanding (MoU) to collaborate on the UAE Healthy Future Study (UAEHF), supporting one of the key Abu Dhabi Vision 2030 objectives of establishing the emirate as a significant knowledge hub in the region.
The MoU reaffirms the parties’ commitment to continue working together on this long-term study which specifically explores the genetic and lifestyle determinants of chronic diseases among Emiratis, to produce meaningful research on chronic disease causes and prevention that is specific to the UAE. Till date 1,800 participants in the study have been generated through the collaboration with Cleveland Clinic Abu Dhabi, Healthpoint and Capital Health Screening Center, part of Mubadala Healthcare’ network.
“By partnering with highly regarded academic, industrial and investment institutions, we can help to develop an ecosystem of world-class healthcare education, medical research and innovation that will ultimately empower healthcare professionals and improve patient outcomes,” said Eng. Abdulla Abdul Aziz Al Shamsi, Head of Mubadala Healthcare.
“We already have an excellent working relationship with NYUAD cooperating on medical research, so we look forward to extending this and collaborating in areas such as innovation in medical devices and education.”
According to the MoU, the two parties will discuss and identify potential synergies and areas for collaboration within healthcare, including research on population health and improving patient outcomes, education and development of talent in the field, and innovations in digital health and medical devices.
NYUAD Provost Fabio Piano said, “As a global university in and of Abu Dhabi, this collaboration is significant to NYU Abu Dhabi as it helps us in supporting Abu Dhabi Vision 2030 objectives, advancing Abu Dhabi as a center of research, ideas, and innovation while promoting a healthier future for the UAE. This agreement is a milestone for NYUAD’s Public Health Research Centre and its pioneering UAE Healthy Future study. One that will enable our researchers to expand their efforts, increase the pool of potential participants, and extend the reach and impact of this important long-term health study.”
Al Shamsi added, “In terms of the MoU, both parties will also explore opportunities to cooperate across a broad range of healthcare issues as Mubadala Healthcare has facilities that cover the entire healthcare continuum, from disease prevention and diagnosis, to emergency and long-term care.”
Mubadala Healthcare assets include imperial College London Diabetes Centre, Cleveland Clinic Abu Dhabi, Healthpoint, Amana Healthcare, National Reference Laboratories, Capital Health Screening Centre, and Abu Dhabi Telemedicine.
